|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Serum matrix metalloproteinases-2,-9 and tissue inhibitors of metalloproteinases-1,-2 in lung cancer-TIMP-1 as a prognostic marker显示文摘 | Ylisirnio S Hoyhtya M Turpeenniemi-Hujanen T | 2000 | Anticancer Res2000，20，2： | 1 |
| 2 | Serum matrix metalloproteinases-2,-9 and tissue inhibitors of metalloproteinases -1,-2 in lung cancer-TIMP-1 as a prognostic marker显示文摘 | Ylisirnio S Hoyhtya M | 2000 | Anticancer Res2000，20，： | 1 |
| 3 | Serum metallo-proteinase 9 levels in patients with coronary artery disease:a novel marker of inflammation显示文摘 | Ferroni P Basili S Hoyhtya M | 2003 | J Invest Med2003，51，9： | 1 |
| 4 | Limited value of preoperative serum analyses of matrix metalloproteinases (MMP-2,MMP-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1,TIMP-2) in colorectal cancer显示文摘 | Hoyhtya M Tavelin B | 2000 | Anticancer Res2000，20，2： | 1 |
| 5 | Expression of tissue inhibitor of metalloproteinases TIMP-2 in human colorectal a predictor of tumour stage 显示文摘 | Ring P Johansson K Hoyhtya M | 1997 | Br J Cancer1997，76，6： | 1 |
| 6 | Serum metallo-proteinase 9 levels in patients with coronary artery disease: a novel marker of inflammation显示文摘 | FeiToni P Basili S Hoyhtya M | 2003 | Invest Med2003，51，： | 1 |
| 7 | Gelatinase A-Immunoreactive protein in ovarian lesions-prognositic value in epithelial ovarian cancer显示文摘 | Westerlund A Apaja-Sarkkinen M Hoyhtya M | 1999 | Gynecol Oncol1999，75，： | 1 |
| 8 | Association of serum MMP-9 with autoantibodies against oxidized LDL显示文摘 | Kalela A Koivu TA Hoyhtya M | 2002 | Atherosclerosis2002，160，1： | 1 |
| 9 | Gelatinase A-immunoreactive protein in ovarian lesions-prognostic value in epithelial ovarian cancer显示文摘 | Westerlund A Apaja S M Hoyhtya M | 1999 | Gynecol Oncol1999，75，： | 1 |
| 10 | Overian cancer cell invasion is inhibited by paclitasel显示文摘 | Westerlund A Hujanen E Hoyhtya M | 1997 | Clin Exp metastasis1997，15，3： | 1 |
| 11 | Serum matrix metalloproteinases-2,-9 and tissue inhibitors of metalloproteinases-1 ,-2 in lung caneer-TIMP-1 as a prognostic marker显示文摘 | Ylisirnio S Hoyhtya M Turpeenniemi-Hujanen T | 2000 | Anticancer Res2000，20，2： | 1 |
| 12 | Serum matrix metalloproteinases- 2, - 9 and tissue inhibitors of metalloproteinases - 1, - 2 in lung cancer - TIMP - 1 as aprognostic marker显示文摘 | Ylisirnio S Hoyhtya M Turpeenniemi H | 2000 | Anticancer Res2000，20，2： | 1 |
| 13 | Association of serum MMP-9 with autoantibodies against oxidized LDL 显示文摘 | Kalela A Koivu T A Hoyhtya M | 2002 | Atherosclerosis2002，160，5： | 1 |
| 14 | Limited value of preoperative serum analyses of matrix metalloproteinases(MMP - 2, MMP- 9)and tissue inhibitor of matrix metalloproteinases(TIMP - 1, TIMP - 2 )in colorectal cancer显示文摘 | Oberg A Hoyhtya M Tavelin B | 1998 | Gut1998，42，5： | 1 |
| 15 | Serum matrix metalloproteinase2, matrix metalloproteinase9 and tissue inhibitor of matrix metalloproteinase 1, 2 in lung cancer-tissue inhibitor of matrix metalloproteinase 1 as a prognostic marker 显示文摘 | Ylisimio S Hoyhtya M Turpeenniemi HT | 2000 | Anticancer Res2000，20，2： | 1 |
| 16 | Serum matrix metalloproteinases-2,-9 and tissue inhibitors of metalloproteinases-1,-2 in lung cancer-TIMP-1 as a prognostic marker显示文摘 | Ylisirnio S Hoyhtya M Turpeenniemi-Hujanen T | 2000 | Anticancer Res2000，20，213： | 1 |
| 17 | Regulation of matrix metalloproteinase expression in tumor invasion显示文摘 | Visscher D W Hoyhtya M Ottosen S K | 1999 | FASEB1999，13，8： | 1 |
| 18 | Ovarian cancer cell invasion is inhibited by paclitaxel 显示文摘 | Westerlund A Hujanen E Hoyhtya M | 1997 | Clin Exp Metastasis1997，15，3： | 1 |
| 19 | Matrix metalloproteinases 2 immunoreactive protein appears early in cervical epithelial dedifferentiation 显示文摘 | Talvensaari A Apaja- Sarkinen M Hoyhtya M | 1999 | Gynecol Oncol1999，72，3： | 1 |
| 20 | Serum matrix metalloproteinases-2, -9 and tissue inhibitiors of metalloproteinases 1, -2 in lung cancer - TIMP-1 as a prognostic marker显示文摘 | Ylisirnio S Hoyhtya M Turpeeniemi-Hujanen T | 2000 | Anticancer Res2000，211，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员